GreenCross Medical Science Corp. (KOSDAQ:A142280) agreed to acquire additional 29.54% stake in CERAGEM Medisys, Inc for KRW 4.6 billion on April 17, 2018. The consideration is paid in cash. Under the terms, GreenCross Medical Science Corp will acquire 9.3 million shares of CERAGEM Medisys, Inc. Post acquisition, GreenCross Medical Science Corp will hold 19.3 million shares (61.41%) in CERAGEM Medisys, Inc. As of December 31, 2017, CERAGEM Medisys, Inc reported total assets of KRW 6.2 billion, net assets of KRW 4.6 billion, sales of KRW 6.9 billion and net loss of current period of KRW 410 million. The transaction is resolved by the Board of Directors of GreenCross Medical Science Corp on April 17, 2018. The transaction is expected to close on May 31, 2018. GreenCross Medical Science Corp. (KOSDAQ:A142280) cancelled the acquisition of additional 29.54% stake in CERAGEM Medisys, Inc on April 17, 2019.